Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment

European Neuropsychopharmacology

Volumn 10, Issue 2, 2000, Pages 105-111

  Jensen, Jens Bitsch ^a,b   Mikkelsen, Jens D ^b   Mørk , Arne ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b H LUNDBECK A S   (Denmark)

Author keywords

Adenylyl cyclase; cAMP; Citalopram; Lithium; mRNA; Serotonin reuptake inhibitor

Indexed keywords

ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; CITALOPRAM; FORSKOLIN; GUANOSINE TRIPHOSPHATE; ISOENZYME; LITHIUM; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ADENYLATE CYCLASE; ANIMALS; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; ISOENZYMES; LITHIUM CHLORIDE; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; TRANSCRIPTION, GENETIC;

EID: 0033999332     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00064-4     Document Type: Article

References (36)

1. Bersudsky Y., Kotler M., Shifrin M., Belmaker R.H. A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. J. Neural Transm. 103:1996;1463-1467. Short communication.
2. Chen J., Rasenick M.M. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J. Pharmacol. Exp. Ther. 275:1995;509-517.
3. Chen J., Rasenick M.M. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J. Neurochem. 64:1995;724-732.
4. Colin S.F., Chang H.C., Mollner S., Pfeuffer T., Reed R.R., Duman R.S., et al. Chronic lithium regulates the expression of adenylate cyclase and Gi- protein alpha subunit in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 88:1991;10634-10637.
5. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 633:1994;297-304.
6. De Montis G.M., Devoto P., Gessa G.L., Porcella A., Serra G., Tagliamonte A. Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats. Eur. J. Pharmacol. 180:1990;169-174.
7. Furuyama T., Inagaki S., Takagi H. Distribution of type II adenylyl cyclase mRNA in the rat brain. Brain Res. Mol. Brain Res. 19:1993;165-170.
8. Glatt C.E., Snyder S.H. Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature. 361:1993;536-538.
9. Hanoune J., Pouille Y., Tzavara E., Shen T., Lipskaya L., Miyamoto N., et al. Adenylyl cyclases: structure, regulation and function in an enzyme superfamily. Mol. Cell Endocrinol. 128:1997;179-194.
10. Horowski R., Sastre-Y-Hernandez M. Clinical effects of the neurotrophic selective cAMP phosphodiesterase inhibitor Rolipram in depressed patients: Global evaluation of the preliminary reports. Curr. Therapeut. Res. 38:1985;23-29.
11. Houslay M.D., Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22:1997;217-224.
12. Lesch K.P., Manji H.K. Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain. Biol. Psych. 32:1992;549-579.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Manier D.H., Eiring A., Shelton R.C., Sulser F. Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology. 15:1996;555-561.
15. Meinkoth J.L., Alberts A.S., Went W., Fantozzi D., Taylor S.S., Hagiwara M., et al. Signal transduction through the cAMP-dependent protein kinase. Mol. Cell Biochem. 127-128:1993;179-186.
16. Menkes D.B., Rasenick M.M., Wheeler M.A., Bitensky M.W. Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science. 219:1983;65-67.
17. Mørk A. Actions of lithium on the cyclic AMP signalling system in various regions of the brain - possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus. Pharmacol. Toxicol. 73:(Suppl 3):1993;1-47.
18. Mørk A., Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol. Psychiatry. 26:1989;279-288.
19. Morrill A.C., Wolfgang D., Levine M.A., Wand G.S. Stress alters adenylyl cyclase activity in the pituitary and frontal cortex of the rat. Life Sci. 53:1993;1719-1727.
20. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53:1989;1644-1647.
21. Newman M.E., Lerer B. Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitisation. Eur. J. Pharmacol. 162:1989;345-352.
22. Newman M.E., Solomon H., Lerer B. Electroconvulsive shock and cyclic AMP signal transduction: effects distal to the receptor. J. Neurochem. 46:1986;1667-1669.
23. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
24. Perez J., Mori S., Caivano M., Popoli M., Zanardi R., Smeraldi E., Racagni G. Effects of fluvoxamine on the protein phosphorylation system associated with rat neuronal microtubules. Eur. Neuropsychopharmacol. 5:1995;65-69.
25. Perez J., Tinelli D., Bianchi E., Brunello N., Racagni G. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology. 4:1991;57-64.
26. Perez J., Tinelli D., Brunello N., Racagni G. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur. J. Pharmacol. 172:1989;305-316.
27. Petersen B., Mørk A. Chronic treatment with citalopram induces noradrenaline receptor hypoactivity. A microdialysis study. Eur. J. Pharmacol. 300:1996;67-70.
28. Rasenick M.M., Chaney K.A., Chen J. G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems. J. Clin. Psych. 57:(Suppl 13):1996;49-55.
29. Shelton R.C., Mainer D.H., Sulser F. cAMP-dependent protein kinase activity in major depression. Am. J. Psych. 153:1996;1037-1042.
30. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36:1996;461-480.
31. Vallejo M. Transcriptional control of gene expression by cAMP-response element binding proteins. J. Neuroendocrinol. 6:1994;587-596.
32. Wolfgang D., Chen I., Wand G.S. Effects of restraint stress on components of adenylyl cyclase signal transduction in the rat hippocampus. Neuropsychopharmacology. 11:1994;187-193.
33. Xia Z., Choi E.J., Wang F., Blazynski C., Storm D.R. Type I calmodulin-sensitive adenylyl cyclase is neural specific. J. Neurochem. 60:1993;305-311.
34. Young L.T., Li P.P., Kish S.J., Siu K.P., Kamble A., Hornykiewicz O., et al. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61:1993;890-898.
35. Young W.S., Mezey E., Siegel R.E. Vasopressin and oxytocin mRNAs in adrenalectomized and Brattleboro rats: analysis by quantitative in situ hybridization histochemistry. Brain Res. 387:1986;231-241.
36. Zanardi R., Racagni G., Smeraldi E., Perez J. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology (Berl). 129:1997;44-47.